3630 results for «240»

Filter By

3630 results

What is a healing-targeted drug-eluting stent and how is it different to a normal stent?

18 May 2021 – From EuroPCR 2021

Watch this session presented by Andreas Baumbach and Patrick W. Serruys in order to understand what is a healing-targeted (HT) drug-eluting stent (DES) and what are the potential benefits, to review recent clinical data of the HT DES from the PIONEER III trial, and to learn about...

What is a healing-targeted drug-eluting stent and how is it different to a normal stent?

FFR-guided PCI optimisation directed by high-definition IVUS

18 May 2021 – From EuroPCR 2021

Watch this session presented by Joost Daemen in order to understand the rationale of low post-PCI FFR, to learn if and how post-PCI FFR can be improved, and to know more about the risk of post-PCI optimisation.

FFR-guided PCI optimisation directed by high-definition IVUS

New, novel Navitor TAVI valve with active paravalvular leak-sealing technology

18 May 2021 – From EuroPCR 2021

Watch this session presented by Lars Sondergaard to learn about the latest TAVI active PVL-sealing technology, to understand the clinical evidence with the active PVL-sealing technology, and to discuss the value that the new, novel Navitor valve brings in today's TAVI market.

View the recording of this EuroPCR 2021 Session...

New, novel Navitor TAVI valve with active paravalvular leak-sealing technology

Guiding primary PCI using high-definition intravascular ultrasound

18 May 2021 – From EuroPCR 2021

Watch this session presented by Joost Daemen in order to understand the pitfalls of primary PCI, to learn how IVUS can improve outcomes, and to understand the importance of plaque and thrombus quantification.

Guiding primary PCI using high-definition intravascular ultrasound

Clinical event reductions in high-risk hypertension patients treated with renal denervation

18 May 2021 – From EuroPCR 2021

Watch this session presented by Roland Schmieder in order to learn about the long-term safety and efficacy of renal denervation in high-risk subgroups from the largest renal denervation data set of real-world patients, to understand how clinical event rates could be reduced following renal denervation as compared...

Clinical event reductions in high-risk hypertension patients treated with renal denervation

BIOSTEMI: translating ultrathin DES technology into superior STEMI patient outcomes

18 May 2021 – From EuroPCR 2021

Watch this session presented by Juan F. Iglesias in order to review the role of ultrathin DES in optimising clinical outcomes in STEMI patients, to learn about the BIOSTEMI trial and its new two-year outcomes, and to assess the impact of the BIOSTEMI trial on your daily practice.

BIOSTEMI: translating ultrathin DES technology into superior STEMI patient outcomes

The uncompromised hemodynamics of the ALLEGRA transfemoral TAVI system in native and small annuli

18 May 2021 – From EuroPCR 2021

Watch this session presented by Raul Moreno and Dave Smith in order to learn about the hemodynamic performance of the ALLEGRA TAVI system, to share the experience of European centres through challenging ALLEGRA cases, and to focus on the outcome of the ALLEGRA TAVI system in small annuli...

The uncompromised hemodynamics of the ALLEGRA transfemoral TAVI system in native and small annuli

Complex PCI with short DAPT: the trade-off between ischaemia and bleeding

18 May 2021 – From EuroPCR 2021

Watch this session presented by Benjamin Faurie, Roxana Mehran and Manel Sabate in order to understand the trade-off between ischaemic risk and bleeding risk, to hear about the results of LM-PCI with Biofreedom Ultra and short DAPT, and to learn how to use short DAPT in patients undergoing complex...

Complex PCI with short DAPT: the trade-off between ischaemia and bleeding

Short DAPT in high bleeding risk: ready for prime time?

20 May 2021 – From EuroPCR 2021

Watch this session presented by Roxana Mehran, Davide Capodanno, Pieter Smits and Marco Valgimigli in order to discuss integrated framework for the decision making on DAPT duration in high bleeding risk patients, to understand the implications of the available evidence and gaps in knowledge, and to learn...

Short DAPT in high bleeding risk: ready for prime time?

Early real-world experience with Tendyne™ TMVR

18 May 2021 – From EuroPCR 2021

Watch this session presented by Stephan von Bardeleben in order to learn about real-world Tendyne results from TENDER EU, the largest reported commercial cohort, to hear expert feedback on the safety and effectiveness of Tendyne TMVI in real-life setting, and to discover how one heart team integrates Tendyne...

Early real-world experience with Tendyne™ TMVR

Complete 2-year follow-up from the Evolut low risk trial

18 May 2021 – From EuroPCR 2021

This session was originally presented during EuroPCR 2021.

Complete 2-year follow-up from the Evolut low risk trial

Presentation of the PCR Tricuspid Focus Group

19 May 2021 – From EuroPCR 2021

This session was originally presented during EuroPCR 2021.

Presentation of the PCR Tricuspid Focus Group

Endovascular aortic repair and case-based discussion of complications during peripheral interventions (Part 1)

20 May 2021 – From EuroPCR 2021

Watch this session if you want to learn more about Endovascular aortic repair and complications during peripheral interventions. It highlights the need for a large toolbox and the importance of pre-procedural planning, ultrasound-guided puncture, and team-working (vascular/heart teams).

This session was originally presented during EuroPCR 2021.

Endovascular aortic repair and case-based discussion of complications during peripheral interventions

EAPCI-PCR Fellows Course: your first TAVI procedure - Session with LIVE demonstration

19 May 2021 – From EuroPCR 2021

Watch this session if you want to learn how to assess a CT scan for a TAVI procedure, to master large bore vascular access and closure, and to learn how to cross the aortic valve and position the valvular prosthesis.

This session was originally presented during EuroPCR...

EAPCI-PCR Fellows Course: your first TAVI procedure

Managing a patient with STEMI and bystander disease in the pandemic (Part 2) - Session with LIVE case

20 May 2021 – From EuroPCR 2021

Watch this session if you want to be updated on developments in treatment of ACS and STEMI, and to discuss diagnosis and treatment for bystander disease.

This session was originally presented during EuroPCR 2021.

Managing a patient with STEMI and bystander disease in the pandemic - Part 2

Current status of renal denervation techniques for the treatment of hypertension (Part 1)

19 May 2021 – From EuroPCR 2021

Watch this session if you want to review the up-to-date indications, device selection and procedural techniques for renal denervation.

This session was originally presented during EuroPCR 2021.

Current status of renal denervation techniques for the treatment of hypertension (Part 1)

EuroPCR 2021 Hotlines / Late-Breaking Trials in CT-based FFR: DISCOVER FLOW & P3

26 May 2021 – From EuroPCR 2021

Find out more about various studies & registries in CT-based FFR:

  • Ten-year outcomes of coronary lesions assessed by CT angiography derived FFR
  • Accuracy of the FFRCT Planner in Complex Coronary Artery Disease
EuroPCR 2021 Hotlines / Late-Breaking Trials in CT-based FFR: DISCOVER FLOW & P3

Managing a patient with STEMI and bystander disease in the pandemic (Part 1) - Session with LIVE demonstration

20 May 2021 – From EuroPCR 2021

Watch this session if you want to be updated on developments in treatment of ACS and STEMI and to discuss diagnosis and treatment for bystander disease.

This session was originally presented during EuroPCR 2021.

Managing a patient with STEMI and bystander disease in the pandemic - Part 1

The role of physiology, CT and intracoronary imaging for the management of multivessel disease (Part 1)

19 May 2021 – From EuroPCR 2021

Watch this session if you want to understand the role of invasive physiology in planning, guiding and evaluating your PCI strategy in MVD, to appreciate the role of intravascular imaging in the optimisation of PCI in such patients and to explore the expanding role of CT...

The role of physiology, CT and intracoronary imaging for the management of multivessel disease (Part 1)

The role of physiology, CT and intracoronary imaging for the management of multivessel disease (Part 2)

19 May 2021 – From EuroPCR 2021

Watch this session if you want to understand the role of invasive physiology in planning, guiding and evaluating your PCI strategy in MVD, to appreciate the role of intravascular imaging in the optimisation of PCI in such patients and to explore the expanding role of CT...

The role of physiology, CT and intracoronary imaging for the management of multivessel disease (Part 2)
Didn’t find what you were looking for?